
Carl Wittwer, MD, PhD, Joins PathogenDx’s Board of Advisors
Scottsdale, AZ, March 26, 2025 — PathogenDx, a leader in next-generation microarray technology for better health and safety, is pleased announce the addition of Carl Wittwer, MD, PhD, to its highly respected Board of Technology […]